NASDAQ · SBRA
Real Estate · REIT - Healthcare Facilities
$19.74
Up+$0.13 (+0.66%)
Updated Nov 1, 2026, 12:14 AM
SID Score
5.3/10
Composite research score
Smart Money
58/100
Neutral
Price performance · SBRA
1M range · 0 trading sessions · Daily adjusted prices
SBRA does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning SBRA.
Company
Market Activity
Research & News
SBRA research
Company profile and research snapshot.
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 19, 2026 | Wells Fargo | Overweight | — |
| Oct 13, 2026 | Barclays | Equal-Weight | — |
| Oct 13, 2026 | UBS | Neutral | — |
| Aug 31, 2026 | Barclays | Equal-Weight | — |
| Aug 31, 2026 | Baird | Neutral | — |
No generated briefing is available yet.
Yahoo · Oct 19, 2026
TUSTIN, Calif., October 19, 2026--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2026 third quarter earnings release on November 2, 2026, after the close of trading.
Benzinga · Oct 19, 2026
Wells Fargo analyst James Feldman maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overweight and lowers the price target from $23 to $21.
Benzinga · Oct 13, 2026
UBS analyst Michael Goldsmith maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and lowers the price target from $21 to $20.
Benzinga · Oct 13, 2026
Barclays analyst Richard Hightower maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Equal-Weight and lowers the price target from $23 to $21.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SBRA.
